Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03255772 · ClinicalTrials.gov registry record
Magnetocardiography Using a Novel Analysis System (Cardioflux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients
A clinical trial of Myocardial Infarction and Acute Coronary Syndrome, sponsored by Genetesis.
- Completed
- Registry status
- 101
- Enrollment target
- 1
- Study location
NCT03255772 is a study of Myocardial Infarction and Acute Coronary Syndrome that has completed, run by Genetesis. The registered enrollment target is 101 participants, below the 4,680-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03255772, a study of Myocardial Infarction and Acute Coronary Syndrome, has completed, sponsored by Genetesis.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
Genetesis is a cardiac diagnostics company which presents a novel magnetocardiogram (MCG) analysis system called CardioFlux. This investigation presents a new, noninvasive diagnostic option to use MCG for rapid diagnosis of acute coronary syndrome. Data from the Cardioflux system will be compared with stress testing methods as well as the results of cardiac catheterization to identify patients with myocardial ischemia. This is a prospective observational single-blinded convenience pilot study of 100 patients placed in the Clinical Decision Unit (CDU) for evaluation of chest pain at St. John Hospital and Medical Center (Detroit, MI). Patients enrolled in the study will also have a 30 and 180 day follow up for analysis of adverse cardiac events.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Magnetocardiography
Study Locations (1)
Michigan
- St. John Hospital and Medical Center - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2017-07-15 |
| Est. Completion | 2018-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03255772
The ClinicalTrials.gov registry entry for NCT03255772 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,680-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (98% lower). The listed sponsor is Genetesis, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which Magnetocardiography is the first listed.
NCT03255772 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03255772 about?
NCT03255772 is a clinical study titled "Magnetocardiography Using a Novel Analysis System (Cardioflux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients". Genetesis is a cardiac diagnostics company which presents a novel magnetocardiogram (MCG) analysis system called CardioFlux. This investigation presents a new, noninvasive diagnostic option to use MCG for rapid diagnosis of acute coronary syndrome. Data from the Cardioflux system will be compared wi...
What is the current status of trial NCT03255772?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2017-07-15. Estimated completion is 2018-05-01.
What conditions does trial NCT03255772 study?
This clinical trial studies the following conditions: Myocardial Infarction, Acute Coronary Syndrome.
What interventions are being tested in trial NCT03255772?
The interventions under investigation include: Magnetocardiography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03255772?
This trial is sponsored by Genetesis, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03255772 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
Women's Heart Attack Research Program: Stress Ancillary Study
RECRUITING · NA
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RECRUITING
-
Heart Attack Research Program: Platelet Sub-Study (HARP)
RECRUITING
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.